Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Enrollment completed in phase III ATX-101 trial for submental fat

Sep. 5, 2012

Novel peptides for skin disorders disclosed by OrganoBalance

Sep. 3, 2012

Research at Kyowa Hakko Kirin produces new calcium channel antagonists

Aug. 31, 2012

Confirmatory U.S. phase III trial begins for Scenesse

Aug. 30, 2012

Zyclara approved in Europe

Aug. 27, 2012

Novel IL-17A/IL-17F inhibitors identified at 4SC

Aug. 21, 2012

Biofrontera and Pelpharma Handels sign distribution agreement

Aug. 14, 2012

VitroGro CE mark approval application referred to U.K.'s MHRA

Aug. 9, 2012

Kinentia Biosciences presents new ERK-2/MMP-1 inhibitors

Aug. 3, 2012

Stiefel acquires anti-inflammatory agent from Welichem Biotech

Aug. 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...